Multiple, bilateral renal oncocytomas are uncommon, and the management of this condition is poorly described. Here, we report a case of multiple, bilateral, biopsy-proven renal oncocytomas that were successfully managed using percutaneous cryoablation. This procedure may serve as a less invasive treatment for patients with multiple, bilateral renal oncocytomas when compared to radical or partial nephrectomy.
Introduction
Benign oncocytomas comprise 3%-7% of renal tumors. [1] Of this, 4%-6% are multifocal and bilateral. [1] Oncocytomas are difficult to distinguish from other renal masses, such as renal cell carcinoma (RCC), without pathologic confirmation. [2] Historically, oncocytomas were managed conservatively until symptomatic, prompting radical or partial nephrectomy. [1] However, percutaneous ablation is a safe, minimally invasive, and effective therapy for small renal masses, including RCC and oncocytomas. [3, 4] Yet, the role of ablation in managing patients with multiple, bilateral oncocytomas is not well described. [5] Here, we present a case of multiple, bilateral renal oncocytomas successfully managed with percutaneous cryoablation.
Case Report
A male patient with a history of coronary artery disease, atrial fibrillation, and prostatectomy presented with vague complaints of nausea and intermittent abdominal pain. A contrast-enhanced computed tomography (CT) revealed multiple, bilateral renal masses [ Figure 1 ]. The differential diagnosis included RCC and oncocytoma. At presentation, the patient denied any dysuria, hematuria, and unintentional weight loss. Due to his significant cardiovascular history, he was referred to interventional radiology for percutaneous cryoablation with concurrent biopsy.
Procedure 1
The largest lesion (an enhancing, 2.5 cm mass in the left kidney) was targeted at the first visit. CT -fluoroscopy was used to guide the ablation. Moderate conscious sedation was administered and 2% lidocaine was used for local anesthesia. 18G core biopsies were obtained from the mass before ablation. After the biopsy, two cryoablation probes (IceRod™ 1.5 and IceSphere™ 1.5; Galil Medical, Arden Hills, MN, USA) were advanced into the mass. Cryoablation was performed with a 10-min freeze cycle, followed by an 8-min passive thaw, a second 10-min freeze cycle, and then active thawing. Intermittent CT was performed to evaluate coverage of the lesion by the ice ball [ Figure 2 ]. A final CT ensured an adequate ablation without immediate complication. The patient was discharged home the same day. The biopsy results confirmed that this mass was an oncocytoma. Typically, we obtain follow-up imaging 3 months after a renal ablation. However, given that this patient had other renal masses, there was continued concern that one of the masses could be RCC. Thus, follow-up imaging was obtained 1 month after the first ablation.
Procedure 2
On the first follow-up, there were two new enhancing masses in the left kidney, The Arab Journal of Interventional Radiology | Volume 3 | Issue 1 | January-June 2019 measuring 2.2 cm and 1 cm. Due to concern for RCC, a second cryoablation procedure was scheduled. Again, CT -fluoroscopy was used to guide the ablation. Moderate conscious sedation was administered and 2% lidocaine was used for local anesthesia. 18G core biopsies were obtained from the largest mass before ablation. After the biopsy, two cryoablation probes (both IceRod™ 1.5) were advanced into the largest mass. A single cryoablation probe (IceRod™ 1.5) was inserted into the smaller lesion. Cryoablation was performed in a similar fashion as the first procedure. Intermittent CT was used to evaluate coverage of the lesion by the ice ball. A final CT demonstrated an adequate ablation without immediate complication. The patient was discharged home the same day. The biopsy results confirmed that the largest mass was an oncocytoma. Once again, due to the concern for RCC, imaging was obtained approximately 6 weeks after the second ablation.
Procedure 3
Follow-up imaging did not show any new or growing lesions but continued concern for concomitant RCC on the right prompted a third cryoablation procedure. At this third procedure, the largest masses on the right were targeted. Both of these masses were enhancing and measured 1.7 cm and 1.3 cm. As before, CT -fluoroscopy was used to guide the ablation and moderate conscious sedation was administered. 2% lidocaine was used for local anesthesia. 18G core biopsies were obtained from the largest mass before ablation. After the biopsy, two cryoablation probes (both IceRod™ 1.5) were advanced into the largest mass. A single cryoablation probe (IceRod™ 1.5) was inserted into the smaller lesion. Cryoablation was performed in a similar fashion as the previous procedures. Intermittent CT was used to evaluate coverage of the lesion by the ice ball. A final CT demonstrated good coverage of the masses without immediate complication. The patient was discharged home the same day. The biopsy results confirmed that the largest mass was an oncocytoma. The patient underwent follow-up imaging at 1 month, which showed no new or enlarging masses. The patient then underwent surveillance imaging at approximately 6-month intervals.
Procedure 4
Approximately 2 years after the third ablation, the patient was noted to have an enlarging, enhancing 2 cm mass in the left kidney; therefore, a fourth ablation procedure was scheduled. CT -fluoroscopy was used to guide the ablation, moderate conscious sedation was administered, and 2% lidocaine was used for local anesthesia. 18G core biopsies were obtained from the mass before ablation. After the biopsy, two cryoablation probes (both IcePearl™ 2.1) were advanced into the mass. Cryoablation was performed in the same manner as the prior procedures. Intermittent CT was used to evaluate coverage of the lesion by the ice ball. A final CT demonstrated an appropriate ablation without immediate complication. The patient was discharged home the same day. The biopsy results confirmed that the largest mass was an oncocytoma. 
Discussion
Prior reports of multiple, bilateral renal oncocytomas have been managed with either surveillance or surgery, including partial or radical nephrectomy. [1] Some reports of percutaneous cryoablation as a treatment for oncocytomas exist [4] although most describe the treatment of a single lesion. The rarity of this condition and lack of long-term outcomes has made it difficult to draw any substantive conclusions on management. Percutaneous ablation is a well-established, minimally invasive treatment for small RCCs with similar oncologic outcomes to partial nephrectomy for T1a disease. [6] Further, ablation is associated with less complications and quicker recovery times, making it an attractive alternative for patients who cannot undergo or do not desire traditional surgery. [6] Here, we used cryoablation for the treatment of multiple, bilateral oncocytomas. In the setting of multiple renal oncocytomas, image-guided ablation appears to have several potential advantages. First, as in this case, it allows for the simultaneous biopsy and treatment of the solid renal mass. Pathologic confirmation of either RCC or oncocytoma is essential in determining further management and/or surveillance. Second, percutaneous ablation is a more nephron-sparing approach than radical nephrectomy. Overall morbidity and mortality may improve if patients can avoid the initiation of dialysis. Third, percutaneous ablation can be performed as an outpatient procedure with comparatively short recovery times. Undoubtedly, percutaneous ablation carries a certain risk of complications even though they are relatively uncommon. For instance, postprocedural pain (7.2%), [7] bleeding (1%-15%), [8] hematuria (1%), [8] and damage to adjacent structures (i.e., ureter and bowel) [9] can occur. Complication rates are known to increase with increasing number of ablation probes, prolonged procedure time, and masses that are endophytic and located in the anterior kidney. [10] Nevertheless, percutaneous ablation of multiple, bilateral renal oncocytomas may be considered for the management of this uncommon pathology.
